Loading...
Loading...
Contributors:
Dataset URI:
mjn93kx46dAdult mammalian Müller glia (MG) cells typically undergo a gliotic response following retinal injury, limiting endogenous neuronal regeneration. Previous studies demonstrated that the potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, PNU-282987, induces a neurogenic response in adult mammalian MG through signaling initiated in retinal pigment epithelial (RPE) cells. In the present study, we further investigate the cellular and transcriptomic responses underlying α7 nAChR-mediated MG reprogramming using primary mouse MG and RPE cell cultures. Primary MG cells from adult mice were co-cultured with RPE cells treated with either PNU-282987 or DMSO, and phenotypic changes associated with proliferation and progenitor formation were evaluated using immunocytochemistry. PNU-282987-treated primary MG cultures demonstrated a significant increase in Ki67-positive and Pax6-positive cells compared to DMSO-control primary MG cultures. To further characterize the responses, RNA sequencing was performed to characterize transcriptomic effects associated with α7 nAChR activation. Differential expression analyses identified several candidate regulators associated with glial plasticity, progenitor formation, and developmental signaling. These results provide insight into receptor-mediated responses that can enhance the neurogenic potential of central nervous system glia. Moreover, these studies are foundational for future experiments examining the precise mechanism of how PNU-282987 elicits changes in adult mammalian MG cells.
Keyword(s):
Glial Cell Biology; Molecular Biology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)